Prestigious NIH Training Grant To Support Doctoral Education in Biomedical Science
The National Institute of General Medical Sciences (NIGMS), a branch of the National Institutes of Health, has awarded UF a competitive T32 Institutional Research Training Grant to support doctoral training in biomedical research.
Sediments Exposed by Glacier Melt Begin Emitting Greenhouse Gases Over Time
UF researchers have led a study that shows that as land is exposed by melting glaciers, chemical reactions in the newly uncovered glacial sediments initially suppress greenhouse gas emissions.
UF Genetics Institute Awarded Prestigious NIH Training Grant To Support Doctoral Education in Biomedical Science
The UF Genetics Institute has been awarded a $2.98 million grant by the National Institute of General Medical Sciences (NIGMS) to support doctoral education in genetics, genomics, and molecular pharmacology.
University of Florida Sets New Records in Technology Transfer Metrics for Fiscal Year 2025
UF has demonstrated its leadership in innovation and technology transfer by setting new records in key metrics for fiscal year 2025, with significant increases in technology disclosures, executed licenses, patent applications, and material transfer agreements.
Scientist’s Cat, Again, Helps Discover New Virus
A UF researcher’s cat caught a shrew carrying a previously unidentified strain of orthoreovirus—an unexpected find that helped researchers better understand the transmission of mule deerpox virus.
Tech Tuesday: University of Florida Lab Hopes To Assist Drivers Better Understand Automated Systems
In this week’s Tech Tuesday, UF Innovate highlights how researchers like Dr. Lan Zheng at UF’s Human Systems Engineering Lab are helping drivers better understand automated driving systems.
UF/IFAS Scientist Uses AI To Target Weeds — Not Nearby Tomatoes – Saving 70% of Herbicide
UF research shows that targeted weed-spraying can help tomato farmers reduce herbicide use by 71%, significantly lowering the amount released into the environment.
Atsena Therapeutics Announces Alignment With FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)
UF startup Atsena Therapeutics received FDA approval to expand its Phase 1/2 LIGHTHOUSE study of ATSN-201 into a pivotal Phase 1/2/3 trial to support a BLA submission for treating X-linked retinoschisis (XLRS).
Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy To Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Solid Biosciences, which acquired UF startup AavantiBio, announced FDA and Health Canada approval to begin clinical trials of SGT-501, a gene therapy targeting CPVT, a severe heart rhythm disorder caused by RYR2 mutations.
New Study Suggests Florida Chagas Disease Transmission
UF researchers, in collaboration with Texas A&M University, have spent the past 10 years investigating the ecology, risk, and vector-borne transmission of Chagas disease in Florida.